4.7 Review

Y Central and peripheral regulations mediated by short-chain fatty acids on energy homeostasis

期刊

TRANSLATIONAL RESEARCH
卷 248, 期 -, 页码 128-150

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.trsl.2022.06.003

关键词

-

资金

  1. NIH [R00 DK107008, R01 DK123098]
  2. DOD [W81XWH-19-PRMRP-DA]
  3. DRTC [DK020595]
  4. National Institutes of Health [R01DK104927, P30DK020595]
  5. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, VA merit [1I01BX003382]

向作者/读者索取更多资源

The human gut microbiota plays a role in obesity, insulin resistance, and the development of type 2 diabetes. Short-chain fatty acids (SCFAs) produced by the gut microbiota have beneficial effects on energy and glucose metabolism. However, the understanding of their involvement in the central nervous system-mediated regulation of metabolism is still limited.
The human gut microbiota influences obesity, insulin resistance, and the subsequent development of type 2 diabetes (T2D). The gut microbiota digests and ferments nutrients resulting in the production of short-chain fatty acids (SCFAs), which generate various beneficial metabolic effects on energy and glucose homeostasis. However, their roles in the central nervous system (CNS)-mediated outputs on the metabolism have only been minimally studied. Here, we explore what is known and future direc-tions that may be worth exploring in this emerging area. Specifically, we searched studies or data in English by using PubMed, Google Scholar, and the Human Metabo-lome Database. Studies were filtered by time from 1978 to March 2022. As a result, 195 studies, 53 reviews, 1 website, and 1 book were included. One hundred and sixty-five of 195 studies describe the production and metabolism of SCFAs or the effects of SCFAs on energy homeostasis, glucose balance, and mental diseases through the gut-brain axis or directly by a central pathway. Thirty of 195 studies show that inappropriate metabolism and excessive of SCFAs are metabolically detrimen-tal. Most studies suggest that SCFAs exert beneficial metabolic effects by acting as the energy substrate in the TCA cycle, regulating the hormones related to satiety reg-ulation and insulin secretion, and modulating immune cells and microglia. These functions have been linked with AMPK signaling, GPCRs-dependent pathways, and inhibition of histone deacetylases (HDACs). However, the studies focusing on the cen-tral effects of SCFAs are still limited. The mechanisms by which central SCFAs regulate appetite, energy expenditure, and blood glucose during different physiological con-ditions warrant further investigation. (Translational Research 2022; 248:128-150)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据